Surgeons Tackle Skin Issues from Weight Loss Drugs

A rise in GLP-1 use leads to increased demand for skin tightening procedures.

Surgeons Address Skin Issues Following Weight Loss Treatments

As the use of GLP-1 weight-loss drugs like Ozempic surges, so does the need for procedures to address skin laxity that often follows rapid weight loss. Dermatologists and surgeons have responded with a range of solutions for sagging skin. New York surgeon Macrene Alexiades reports success with radiofrequency treatments combined with PRP and fillers. Meanwhile, dermatologist Simon Ourian emphasizes restoring collagen and muscle mass with his unique protocols. Techniques such as Ellacor fractional micro-coring are also gaining traction for providing non-invasive skin tightening. In addition, new skincare products designed for GLP-1 users are hitting the market, further demonstrating the impact that these weight-loss medications are having on the cosmetic industry.

The growing popularity of GLP-1 drugs highlights a troubling side effect: sagging skin. While these medications help many achieve weight loss, they often do not consider the bodily changes that come with significant fat reduction. Surgeons and dermatologists are now adapting to fill this gap, creating a booming marketplace for skin rejuvenation procedures and products. This scenario emphasizes the need for holistic approaches to weight loss that consider physical results beyond numbers on a scale. As consumers become more aware of the aesthetic repercussions of rapid weight loss, it is likely we will see an increasing integration of nutrition, fitness, and skincare treatments in future health solutions.

Highlights

The rise of GLP-1 usage is reshaping traditional approaches to weight loss and skin health.